IIPLA News
Thursday, February 16, 2017

CETA’s Intellectual Property Provisions Set to Transform Canada-EU Trade Relations

The Comprehensive Economic and Trade Agreement introduces key IP reforms including treaty accession, geographical indication recognition, and enhanced pharmaceutical patent protec…

IIPLA News Deskanonymous access0 articles left this week
CETA’s Intellectual Property Provisions Set to Transform Canada-EU Trade Relations

The Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union has been ratified by the European Parliament and is poised to significantly impact intellectual property (IP) rights and trade between the two jurisdictions. Designed to eliminate 98% of trade tariffs, CETA includes several IP-related provisions that will affect companies seeking to protect and commercialize their IP assets across borders.

A central feature of CETA is Canada’s commitment to join key international IP treaties, including the Madrid System for trademarks and the Hague System for industrial designs. This move will require Canada to continue updating its domestic IP legislation to align more closely with international standards. Once Canada accedes to these treaties, applicants will benefit from streamlined processes and reduced costs when extending trademark and design protections internationally.

Currently, Canadian applicants must file separate local applications—either nationally within Canada or EU member states, or regionally for EU-wide protection. Although Canada has recently adopted the Nice Agreement classification system for trademarks, full integration into international registration systems remains pending.

CETA also introduces mutual recognition of Geographical Indications (GIs) between Canada and the EU. This is particularly significant for European producers of region-specific agricultural products such as Parmigiano Reggiano cheese and Parma ham. The agreement will help prevent issues like those faced by Prosciutto di Parma producers, who were previously hindered by conflicting Canadian trademarks blocking the use of the Parma name.

Pharmaceutical patents receive special attention under CETA, with provisions granting sui generis protection that extends patent terms by an additional two years. The agreement also facilitates the entry of generic medicines into the Canadian market. While both Canada and the EU are already parties to major international patent treaties, CETA’s patent provisions do not introduce substantial new obligations beyond existing frameworks.

Beyond patents and trademarks, CETA establishes common rules for copyright enforcement, including criminalizing “camcording” in movie theaters to combat piracy. The agreement also harmonizes enforcement measures and border controls to better prevent counterfeiting and protect IP rights.

Despite the European Parliament’s ratification, CETA’s full implementation requires approval from all EU member states’ national parliaments. Once fully in force, these IP provisions are expected to enhance legal certainty and reduce barriers for businesses operating between Canada and the EU, fostering a more integrated and efficient trade environment.

Companies engaged in cross-border trade and IP protection should closely monitor the final ratification process and prepare for the legislative and procedural changes that CETA will bring to the intellectual property landscape.

Share This Article
Ready-to-post copy includes the article link.

CETA’s Intellectual Property Provisions Set to Transform Canada-EU Trade Relations The Canada-European Union Trade Agreement (CETA) promises to reshape intellectual property rights management between Canada and the EU. By removing tariffs and aligning IP laws, CETA facilitates cross-border trade and s... Read the full IIPLA article: https://iipla.org/news/ceta-s-intellectual-property-provisions-set-to-transform-canada-eu-trade-relations

Related Coverage

Continue in the newsroom

Back to newsroom